We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study (ACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04681092
Recruitment Status : Completed
First Posted : December 23, 2020
Last Update Posted : April 12, 2022
Akston Biosciences Corporation
Information provided by (Responsible Party):
Schelto Kruijff, MD PhD, University Medical Center Groningen